Brain Advance Access published online on November 14, 2006
Brain, doi:10.1093/brain/awl263
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratory of Transcription Regulation, Department of Cell Biology, Nencki Institute of Experimental Biology, Warsaw, Poland
* To whom correspondence should be addressed. The invasion of tumour cells into brain tissue is a pathologic hallmark of WHO grades II-IV gliomas and contributes significantly to the failure of current therapeutic treatments. Activated microglial cells are abundant in brain tumours and may support tumour invasiveness. We have previously demonstrated that cyclosporin A (CsA) can affect growth of glioma cells in vitro by inhibiting signalling pathways, which are essential for tumour proliferation and invasiveness. In this work, we demonstrate that migration of EGFP-transfected glioblastoma cells in organotypic brain slices was significantly inhibited by treatment with CsA. On average 77% of untreated cells migrated beyond 500 µm, while only 28-33% cells migrated as far in the brain slices treated with CsA (P < 0.001). This inhibitory effect on glioblastoma invasion was lost when glioblastoma cells were injected into microglia-depleted brain slices. Moreover, CsA significantly inhibits intracranial glioma growth in vivo. We demonstrate that microglia-derived factors increase glioma invasiveness in Matrigel assay in vitro and this is associated with activation of the PI-3K/Akt signalling pathway. The invasion promoting effect of microglia is abolished in the presence of CsA. Furthermore, glioma-derived soluble factors induce morphological transformation of microglia and activate MAPK signalling, although production of pro-inflammatory factors was not observed. Our findings that CsA interferes at clinically relevant concentrations with the tumour-promoting role of microglia and impairs invasive growth of glioma cells in vivo may provide a novel therapeutic strategy against gliomas.
Received February 21, 2006
Revised June 29, 2006
Accepted August 14, 2006
Article
The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A
Marcin Sliwa 1, Darko Markovic 2, Konrad Gabrusiewicz 1, Michael Synowitz 3, Rainer Glass 2, Malgorzata Zawadzka 1, Aleksandra Wesolowska 1, Helmut Kettenmann 2, and Bozena Kaminska 1 *
2 Cellular Neuroscience Group, Max Delbrück Center for Molecular Medicine (MDC), Helios Hospital Berlin, Berlin, Germany
3 Cellular Neuroscience Group, Max Delbrück Center for Molecular Medicine (MDC), Helios Hospital Berlin, Berlin, Germany; Department of Neurosurgery, Helios Hospital Berlin, Berlin, Germany
Bozena Kaminska, E-mail: bozenakk{at}nencki.gov.pl
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Rodero, Y. Marie, M. Coudert, E. Blondet, K. Mokhtari, A. Rousseau, W. Raoul, C. Carpentier, F. Sennlaub, P. Deterre, et al. Polymorphism in the Microglial Cell-Mobilizing CX3CR1 Gene Is Associated With Survival in Patients With Glioblastoma J. Clin. Oncol., December 20, 2008; 26(36): 5957 - 5964. [Abstract] [Full Text] [PDF] |
||||
